Europa Biosite today announces the appointment of Claudia Berrón as Chief Executive Officer, effective 1st April 2026.

Claudia joins Europa Biosite at an important stage in its development, with a strong foundation in the life sciences and biopharma sectors and significant opportunities to expand its market position.

“Claudia is a highly regarded leader with a proven ability to drive growth, strengthen performance, and build high-performing teams,” said Kate Swann, Chair of Europa Biosite. “The Board is confident she is the right leader to guide Europa Biosite through its next phase, with a clear focus on customers, execution, and value creation.”

Claudia will lead the company with a focus on accelerating growth, expanding capabilities, and delivering high-quality solutions to customers and partners across the life sciences ecosystem.

Claudia Berrón said “I am excited to join Europa Biosite at this important moment. My focus will be on working closely with our teams, suppliers, and customers to build on the strong foundation already in place and execute with clarity and discipline. We have a strong opportunity to accelerate our position in the European life sciences ecosystem by strengthening our role as a trusted technical partner and expanding the depth of our specialized solutions to better serve our customers.”

Tim Hiddemann, interim CEO, said “It was truly rewarding to serve as interim CEO over the last five months. We have made great progress in adopting a group approach in key areas and are off to a good start in terms of financials in 2026. I am very confident that Claudia will successfully build on this foundation and execute against our growth objectives. I will serve as non-executive board member and continue to support Europa Biosite in this role.”

Claudia brings nearly three decades of international leadership experience across the life sciences and biopharma sectors. Over the past 11 years at Avantor, she has led global businesses, most recently as Senior Vice President and General Manager, driving strategy, commercial growth, operational performance, and innovation. She has a strong track record of building high-performing teams and delivering results in complex, technical environments.